Zobrazeno 1 - 10
of 666
pro vyhledávání: '"M. Kraj"'
Autor:
Kamil M Kraj
Publikováno v:
Journal of Management and Financial Sciences. :73-97
As discussed in the literaturę, more and more transnational corporations (TNCs) were attaching importance to research and development (R&D) activity from the 1970s through the 2000s. This growing involvement of TNCs in R&D resulted in their dominant
Publikováno v:
Vox Sanguinis. 74:31-35
Microcolumn tests are useful for serological investigations, although because of their high sensitivity, false-positive results might be expected, e.g. in hypergammaglobulinemia. The aim of this study was to evaluate these tests in multiple myeloma.P
Autor:
Bellaver, Emyr Hiago1 hi.agobellaver@hotmail.com, Militão da Costa, Ingrid2 ingrid.costa@edu.udesc.br, Redin, Eduarda Eliza2 eduardaredin@gmail.com, Moroni, Liziane Schittler2 liziane.schittler@udesc.br, Kempka, Aniela Pinto1,2 aniela.kempka@udesc.br
Publikováno v:
Intelligent Pharmacy. Aug2024, Vol. 2 Issue 4, p467-484. 18p.
Autor:
Kanecki, Krzysztof1 kanecki@mp.pl, Nitsch-Osuch, Aneta1, Goryński, Paweł2, Kosinska, Irena1, Kozłowska, Aleksandra1, Okreglicka, Katarzyna1, Tyszko, Piotr Z.3
Publikováno v:
Archives of Medical Science. Aug2024, Vol. 20 Issue 4, p1138-1142. 5p.
Publikováno v:
Acta poloniae pharmaceutica.
Osteolytic bone destruction caused by increase of osteolytic activity is a major manifestation of multiple myeloma (MM). Pamidronate (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate) inhibits osteoclastic activity and reduces bone resorption.Since O
Publikováno v:
Clinical hemorheology and microcirculation. 21(2)
Hemorheological disturbances in patients with monoclonal gammapathies are widely known, but there is little information about microcirculation in these patients. The following study was performed to examine skin microcirculation and its relationship
Publikováno v:
Polski tygodnik lekarski (Warsaw, Poland : 1960). 51(23-26)
This studies included 15 children with burns involving 10-55% of the whole body surface, treated at the two surgical departments in Poland. All patients have been given 0.5 mL of a 15% solution of anti-Pseudomonas immunoglobulin in a deep i.m. inject
Publikováno v:
Materia medica Polona. Polish journal of medicine and pharmacy. 27(3)
15 multiple myeloma patients with severe granulocytopenia after chemotherapy were treated with recombinant human granulocyte colony stimulating factor (Neupogen; Roche). Granulocyte colony stimulating factor (G-CSF) was given s.c. usually in a dose o
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S3
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S4